4//SEC Filing
AGIOS PHARMACEUTICALS INC 4
Accession 0001209191-15-080927
$AGIOCIK 0001439222operating
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 4:19 PM ET
Size
18.1 KB
Accession
0001209191-15-080927
Insider Transaction Report
Form 4
Higgons John Duncan
Chief Operating Officer10% Owner
Transactions
- Sale
Common stock
2015-11-16$61.51/sh−20,000$1,230,200→ 81,835 total - Exercise/Conversion
Stock option (right to buy)
2015-11-16−6,612→ 205,022 totalExercise: $2.34Exp: 2022-04-05→ Common stock (6,612 underlying) - Exercise/Conversion
Common stock
2015-11-16$0.47/sh+10,909$5,127→ 92,744 total - Exercise/Conversion
Common stock
2015-11-16$2.34/sh+6,612$15,472→ 101,835 total - Exercise/Conversion
Stock option (right to buy)
2015-11-16−10,909→ 214,113 totalExercise: $0.47Exp: 2021-03-01→ Common stock (10,909 underlying) - Exercise/Conversion
Stock option (right to buy)
2015-11-16−2,479→ 211,634 totalExercise: $0.47Exp: 2021-03-01→ Common stock (2,479 underlying) - Exercise/Conversion
Common stock
2015-11-16$0.47/sh+2,479$1,165→ 95,223 total
Footnotes (6)
- [F1]This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F3]The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $60.32 to $62.77. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price
- [F4]This option was granted on March 2, 2011. The shares underlying this option vest as to 25% of the shares on January 31, 2012, with the remaining 75% vesting in 36 equal monthly installments thereafter.
- [F5]This option was granted on March 2, 2011 for the purchase of 3,636 shares of common stock. The option vests as to 33% of the underlying shares upon the achievement of a performance milestone and with the remaining 67% vesting in 24 equal monthly installments thereafter. The performance criteria for the performance milestone were met on July 19, 2013.
- [F6]This option was granted on April 6, 2012 for the purchase of 63,636 shares of common stock. The option vests as to 25% of the underlying shares upon the achievement of a performance milestone, as to an additional 50% upon the achievement of a second performance milestone, and as to the remaining 25% on the first anniversary of the first date that both performance milestones were achieved. The performance criteria for the first performance milestone were met on March 18, 2013, resulting in the vesting of the option as to 15,909 shares. The performance criteria for the second performance milestone were met on April 4, 2014, resulting in the vesting of the option as to 31,818 shares. The remaining 15,908 shares vested on April 4, 2015.
Documents
Issuer
AGIOS PHARMACEUTICALS INC
CIK 0001439222
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001439222
Filing Metadata
- Form type
- 4
- Filed
- Nov 17, 7:00 PM ET
- Accepted
- Nov 18, 4:19 PM ET
- Size
- 18.1 KB